Eli Lilly’s weight-loss pill meets target in key diabetes trial
Aug 26 (Reuters) – Eli Lilly (LLY.N), opens new tab said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of …